These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25622528)

  • 1. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study.
    Segovia-Mendoza M; Jurado R; Mir R; Medina LA; Prado-Garcia H; Garcia-Lopez P
    BMC Cancer; 2015 Jan; 15():21. PubMed ID: 25622528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
    García-López P; Rodríguez-Dorantes M; Pérez-Cárdenas E; Cerbón M; Mohar-Betancourt A
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):533-40. PubMed ID: 15138713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death.
    Lo Nigro C; Arnolfo E; Taricco E; Fruttero A; Russi EG; Lucio F; Ribero S; Comino A; Merlano M; Ungari S
    Anticancer Drugs; 2007 Jul; 18(6):659-67. PubMed ID: 17762394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.
    Jurado R; Lopez-Flores A; Alvarez A; García-López P
    Oncol Rep; 2009 Nov; 22(5):1237-45. PubMed ID: 19787245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction.
    Kleibeuker EA; Ten Hooven MA; Castricum KC; Honeywell R; Griffioen AW; Verheul HM; Slotman BJ; Thijssen VL
    Cancer Med; 2015 Jul; 4(7):1003-15. PubMed ID: 25828633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
    Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
    Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of mifepristone on DNA repair genes and cisplatin sensitivity in human ovarian cancer drug-resistance cells].
    Liu GY; Qu QX; Mi RR; Qi J
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):132-5. PubMed ID: 18683754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation.
    Ye Y; Xu W; Zhong W; Li Y; Wang C
    Mol Cell Biochem; 2012 Apr; 363(1-2):191-202. PubMed ID: 22147199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an in vitro chemo-radiation response assay for cervical carcinoma.
    Monk BJ; Burger RA; Parker R; Radany EH; Redpath L; Fruehauf JP
    Gynecol Oncol; 2002 Nov; 87(2):193-9. PubMed ID: 12477451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
    Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
    Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model.
    Heravi M; Tomic N; Liang L; Devic S; Holmes J; Deblois F; Radzioch D; Muanza T
    Anticancer Drugs; 2012 Jun; 23(5):525-33. PubMed ID: 22357220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
    Bonner JA; Willey CD; Yang ES; Dobelbower MC; Sanford LL; Bright SJ; Buchsbaum DJ; Raisch KP
    Radiother Oncol; 2011 Oct; 101(1):183-9. PubMed ID: 21722984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its mechanism.
    Li C; Ye H
    Eur J Gynaecol Oncol; 2013; 34(2):142-7. PubMed ID: 23781585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API5 induces cisplatin resistance through FGFR signaling in human cancer cells.
    Jang HS; Woo SR; Song KH; Cho H; Chay DB; Hong SO; Lee HJ; Oh SJ; Chung JY; Kim JH; Kim TW
    Exp Mol Med; 2017 Sep; 49(9):e374. PubMed ID: 28883546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.
    Arienti C; Zoli W; Pignatta S; Carloni S; Paganelli G; Ulivi P; Romeo A; Menghi E; Sarnelli A; Medri L; Polico R; Silvestrini R; Tesei A
    J Cell Physiol; 2014 Oct; 229(10):1548-56. PubMed ID: 24591063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells.
    Li JL; Wang JP; Chang H; Deng SM; Du JH; Wang XX; Hu HJ; Li DY; Xu XB; Guo WQ; Song YH; Guo Z; Sun MX; Wu YW; Liu SB
    Cancer Med; 2019 Dec; 8(18):7774-7780. PubMed ID: 31670906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro.
    Zhou HJ; Zhang JL; Li A; Wang Z; Lou XE
    Cancer Chemother Pharmacol; 2010 May; 66(1):21-9. PubMed ID: 19756601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.